Amitrole
|
CAS
61-82-5
|
C2H4N4
|
RTECS
XZ3850000
|
Synonyms & Trade Names
Aminotriazole; 3-Aminotriazole; 2-Amino-1,3,4-triazole; 3-Amino-1,2,4-triazole
|
DOT ID & Guide
|
Exposure
Limits
|
NIOSH REL: Ca TWA 0.2 mg/m3 See Appendix A
|
|
OSHA PEL†: none
|
IDLH
Ca [N.D.]
See: IDLH INDEX
|
Conversion
|
Physical Description
Colorless to white, crystalline powder. [herbicide] [Note: Odorless when pure.]
|
MW: 84.1
|
BP: ?
|
MLT: 318°F
|
Sol(77°F): 28%
|
VP: <0.000008 mmHg
|
IP: ?
|
|
Sp.Gr: 1.14
|
Fl.P: NA
|
UEL: NA
|
LEL: NA
|
|
|
Noncombustible Solid, but may be dissolved in flammable liquids.
|
Incompatibilities & Reactivities
Light (decomposes), strong oxidizers [Note: Corrosive to iron, aluminum & copper.]
|
Measurement Methods
NIOSH 0500; OSHA PV2006
See: NMAM or OSHA Methods |
Personal Protection & Sanitation (See protection)
Skin: Prevent skin contact
Eyes: Prevent eye contact
Wash skin: Daily
Remove: When wet or contaminated
Change: Daily
Provide: Eyewash, Quick drench
|
First Aid (See procedures)
Eye: Irrigate immediately
Skin: Water wash immediately
Breathing: Respiratory support
Swallow: Medical attention immediately
|
Respirator Recommendations
NIOSH
At concentrations above the NIOSH REL, or where there is no REL, at any detectable concentration:
(APF = 10,000) Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode
(APF = 10,000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus
Escape:
(APF = 50) Any air-purifying, full-facepiece respirator (gas mask) with a chin-style, front- or back-mounted organic vapor canister having an N100, R100, or P100 filter. Click here for information on selection of N, R, or P filters./Any appropriate escape-type, self-contained breathing apparatus
Important additional information about respirator selection
|
Exposure Routes
inhalation, ingestion, skin and/or eye contact
|
Symptoms
Irritation eyes, skin; dyspnea (breathing difficulty), muscle spasms, ataxia, anorexia, salivation, increased body temperature; lassitude (weakness, exhaustion), skin dryness, depression (thyroid function suppression)
|
Target Organs
Eyes, skin, thyroid
Cancer Site
[in animals: liver, thyroid & pituitary gland tumors]
|
|
See also: INTRODUCTION
See ICSC CARD: 0631 |
